Published in Acta Neuropathol on January 01, 1985
Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci U S A (1997) 4.73
FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol (2007) 2.75
Synaptic regulation of protein synthesis and the fragile X protein. Proc Natl Acad Sci U S A (2001) 2.09
The state of synapses in fragile X syndrome. Neuroscientist (2009) 2.07
The fragile X syndrome. J Med Genet (1998) 2.00
Visualization of RNA-protein interactions in living cells: FMRP and IMP1 interact on mRNAs. EMBO J (2004) 1.99
Fragile X mental retardation protein regulates translation by binding directly to the ribosome. Mol Cell (2014) 1.83
FMR1: a gene with three faces. Biochim Biophys Acta (2009) 1.77
Delayed stabilization of dendritic spines in fragile X mice. J Neurosci (2010) 1.69
Cell surface heparan sulfate proteoglycan syndecan-2 induces the maturation of dendritic spines in rat hippocampal neurons. J Cell Biol (1999) 1.60
Pharmacogenetic inhibition of eIF4E-dependent Mmp9 mRNA translation reverses fragile X syndrome-like phenotypes. Cell Rep (2014) 1.55
Longitudinal changes in cognitive and adaptive behavior scores in children and adolescents with the fragile X mutation or autism. J Autism Dev Disord (2002) 1.54
Drosophila fragile X mental retardation protein developmentally regulates activity-dependent axon pruning. Development (2008) 1.52
The FMR1 gene and fragile X-associated tremor/ataxia syndrome. Am J Med Genet B Neuropsychiatr Genet (2009) 1.37
Autism: the point of view from fragile X studies. J Autism Dev Disord (1998) 1.36
A mouse model of the human Fragile X syndrome I304N mutation. PLoS Genet (2009) 1.36
Fragile X syndrome and targeted treatment trials. Results Probl Cell Differ (2012) 1.27
Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A (2002) 1.25
Physiological activation of synaptic Rac>PAK (p-21 activated kinase) signaling is defective in a mouse model of fragile X syndrome. J Neurosci (2010) 1.22
Temporal requirements of the fragile X mental retardation protein in the regulation of synaptic structure. Development (2008) 1.21
Altered structural and functional synaptic plasticity with motor skill learning in a mouse model of fragile X syndrome. J Neurosci (2013) 1.20
Disruption of Arp2/3 results in asymmetric structural plasticity of dendritic spines and progressive synaptic and behavioral abnormalities. J Neurosci (2013) 1.19
Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Synaptic Neurosci (2010) 1.18
Altered differentiation of neural stem cells in fragile X syndrome. Proc Natl Acad Sci U S A (2005) 1.16
The trouble with spines in fragile X syndrome: density, maturity and plasticity. Neuroscience (2012) 1.15
Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice. PLoS One (2011) 1.15
Fragile X syndrome. Molecular and clinical insights and treatment issues. West J Med (1997) 1.09
Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model. J Neurosci (2014) 1.06
Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. Proc Natl Acad Sci U S A (2013) 1.04
Altered Neuronal and Circuit Excitability in Fragile X Syndrome. Neuron (2015) 1.03
Fragile X mental retardation protein regulates new neuron differentiation in the adult olfactory bulb. J Neurosci (2011) 1.00
Neuroanatomy in fragile X females: the posterior fossa. Am J Hum Genet (1991) 0.99
Accelerators, Brakes, and Gears of Actin Dynamics in Dendritic Spines. Open Neurosci J (2009) 0.99
The fragile X mental retardation protein in circadian rhythmicity and memory consolidation. Mol Neurobiol (2009) 0.99
Early life stress inhibits expression of a novel innate immune pathway in the developing hippocampus. Neuropsychopharmacology (2011) 0.99
Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant. Psychopharmacology (Berl) (2012) 0.98
Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development. Psychopharmacology (Berl) (2014) 0.95
Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome. Neural Plast (2012) 0.94
Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase. Dis Model Mech (2011) 0.94
Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders. Brain Res (2014) 0.93
Activity-dependent modulation of neural circuit synaptic connectivity. Front Mol Neurosci (2009) 0.93
Characterisation of Fmrp in zebrafish: evolutionary dynamics of the fmr1 gene. Dev Genes Evol (2005) 0.92
Fruit flies and intellectual disability. Fly (Austin) (2009) 0.92
White matter microstructural abnormalities in girls with chromosome 22q11.2 deletion syndrome, Fragile X or Turner syndrome as evidenced by diffusion tensor imaging. Neuroimage (2013) 0.91
Casting a net on dendritic spines: the extracellular matrix and its receptors. Dev Neurobiol (2011) 0.90
Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome. Mol Autism (2011) 0.89
Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome. Psychopharmacology (Berl) (2010) 0.89
Modeling fragile X syndrome in the Fmr1 knockout mouse. Intractable Rare Dis Res (2014) 0.88
Fragile X Syndrome and Alzheimer's Disease: Another story about APP and beta-amyloid. Curr Alzheimer Res (2010) 0.87
Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice. Neuroscience (2013) 0.87
Stimulated emission depletion (STED) microscopy reveals nanoscale defects in the developmental trajectory of dendritic spine morphogenesis in a mouse model of fragile X syndrome. J Neurosci (2014) 0.86
Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders. Prog Neurobiol (2012) 0.86
Auditory brain-stem responses in the fragile X syndrome. Am J Hum Genet (1988) 0.86
Activity-dependent regulation of dendritic growth and maintenance by glycogen synthase kinase 3β. Nat Commun (2013) 0.86
Dendritic spine dysgenesis in autism related disorders. Neurosci Lett (2015) 0.85
Matrix metalloproteinase-9 involvement in the structural plasticity of dendritic spines. Front Neuroanat (2014) 0.85
Therapeutic potential of metabotropic glutamate receptor modulators. Curr Neuropharmacol (2012) 0.85
Fragile x mental retardation 1 and filamin a interact genetically in Drosophila long-term memory. Front Neural Circuits (2010) 0.85
Fragile X mental retardation protein regulates trans-synaptic signaling in Drosophila. Dis Model Mech (2013) 0.84
Environmental enrichment reveals effects of genotype on hippocampal spine morphologies in the mouse model of Fragile X Syndrome. Cereb Cortex (2013) 0.84
mTOR, a Potential Target to Treat Autism Spectrum Disorder. CNS Neurol Disord Drug Targets (2016) 0.84
Fragile X mental retardation protein is required for programmed cell death and clearance of developmentally-transient peptidergic neurons. Dev Biol (2011) 0.83
Input transformation by dendritic spines of pyramidal neurons. Front Neuroanat (2014) 0.81
Subcellular localization of fragile X mental retardation protein with the I304N mutation in the RNA-binding domain in cultured hippocampal neurons. Cell Mol Neurobiol (2001) 0.81
Synaptic NMDA receptor-mediated currents in anterior piriform cortex are reduced in the adult fragile X mouse. Neuroscience (2012) 0.80
Early social enrichment rescues adult behavioral and brain abnormalities in a mouse model of fragile X syndrome. Neuropsychopharmacology (2015) 0.80
Role of astrocyte-synapse interactions in CNS disorders. J Physiol (2016) 0.80
New innovations: therapeutic opportunities for intellectual disabilities. Ann Neurol (2013) 0.80
The fragile X syndrome. J Inherit Metab Dis (1997) 0.80
Dendrite and spine modifications in autism and related neurodevelopmental disorders in patients and animal models. Dev Neurobiol (2016) 0.80
In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders. Neural Plast (2015) 0.79
miR-132 Regulates Dendritic Spine Structure by Direct Targeting of Matrix Metalloproteinase 9 mRNA. Mol Neurobiol (2015) 0.79
Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue. Sci Rep (2016) 0.79
Dendritic spine plasticity as an underlying mechanism of neuropathic pain: commentary on Tan et al. Exp Neurol (2011) 0.79
Fragile X syndrome: an aging perspective. Dev Disabil Res Rev (2013) 0.79
Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo. J Neurosci (2016) 0.78
The role of glycogen synthase kinase-3 signaling in neurodevelopment and fragile X syndrome. Int J Physiol Pathophysiol Pharmacol (2012) 0.78
Review of targeted treatments in fragile X syndrome. Intractable Rare Dis Res (2016) 0.77
Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety. J Neurodev Disord (2017) 0.76
A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptoms. EMBO Mol Med (2017) 0.76
A dual comparative approach: integrating lines of evidence from human evolutionary neuroanatomy and neurodevelopmental disorders. Brain Behav Evol (2014) 0.75
Fragile-X syndrome: genetic aspects and stomatologic evaluations. Oral Implantol (Rome) (2011) 0.75
Decreased cohesin in the brain leads to defective synapse development and anxiety-related behavior. J Exp Med (2017) 0.75
Cellular distribution of the fragile X mental retardation protein in the mouse brain. J Comp Neurol (2016) 0.75
Fragile X targeted pharmacotherapy: lessons learned and future directions. J Neurodev Disord (2017) 0.75
Clinical staging of chronic lymphocytic leukemia. Blood (1975) 7.29
Testicular volume during adolescence. Cross-sectional and longitudinal studies. Helv Paediatr Acta (1974) 5.18
Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. Science (1977) 4.59
Conference report: International Workshop on the fragile X and X-linked mental retardation. Am J Med Genet (1984) 2.49
Dendritic spine "dysgenesis" and mental retardation. Science (1974) 2.44
Familial sex-linked mental retardation. Can Med Assoc J (1962) 2.30
The formation of synaptic junctions in developing rat brain: a quantitative electron microscopic study. Brain Res (1967) 1.90
X-linked mental retardation and-or hydrocephalus. Clin Genet (1972) 1.81
The syndrome of sex-linked hydrocephalus. Arch Dis Child (1961) 1.77
X-linked mental retardation associated with macro-orchidism. J Med Genet (1975) 1.62
Inherited congenital normofunctional testicular hyperplasia and mental deficiency. A corroborative study. Hum Genet (1978) 1.56
An X-linked, recessively inherited syndrome characterized by grave mental deficiency, epilepsy, and endocrine disorder. Acta Med Scand (1962) 1.51
Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi study. J Comp Neurol (1976) 1.49
Structural abnormalities of the cerebral cortex in human chromosomal aberrations: a Golgi study. Brain Res (1972) 1.39
Dendritic development in neocortex of children with mental defect and infantile spasms. Neurology (1974) 1.37
Rapid processing of primary embryonic tissues for chromosome banding pattern analysis. Cytogenetics (1972) 1.33
Inherited congenital normofunctional testicular hyperplasia and mental deficiency. Hum Genet (1976) 1.27
Hereditary stenosis of the aqueduct of Sylvius as a cause of congenital hydrocephalus. Brain (1949) 1.24
X-linked recessively inherited non-specific mental retardation. Report of a large family. Ann Genet (1977) 1.23
Marker (X)-linked mental retardation. Adv Hum Genet (1983) 1.20
Autism and mental retardation: neuropathologic studies performed in four retarded persons with autistic behavior. Arch Neurol (1980) 1.19
Abnormal neuronal development in the visual cortex of the human fetus and infant with down's syndrome. A quantitative and qualitative Golgi study. Brain Res (1981) 1.17
X-linked mental deficiency megalotestes syndrome. JAMA (1977) 1.17
HEREDITARY PARTIAL AGENESIS OF CORPUS CALLOSUM; BIOCHEMICAL AND PATHOLOGICAL STUDIES. Arch Neurol (1964) 1.10
The aging human Betz cell. Exp Neurol (1977) 1.07
Autism is associated with the fragile-X syndrome. J Autism Dev Disord (1982) 1.05
Effect of prednisolone upon normal and pathologic human spermatogenesis. Fertil Steril (1966) 1.03
Spine distribution along the apical dendrites of the pyramidal neurons in Down's syndrome. A quantitative Golgi study. Acta Neuropathol (1980) 1.01
Screening for fragile X syndrome by testicular size measurement. Lancet (1981) 0.99
Fragile X syndrome: associated neurological abnormalities and developmental disabilities. Ann Neurol (1985) 0.97
X-linked aqueductal stenosis. Clin Genet (1977) 0.97
The X-linked syndrome of macroorchidism and mental retardation: further observations. Am J Med Genet (1978) 0.92
Testicular size in fetal fragile X syndrome. Lancet (1983) 0.91
X-linked mental retardation and fragile-X or marker-X syndrome. Pediatrics (1982) 0.89
Diagnosis of the fragile X syndrome (Martin-Bell syndrome). Clinical findings in 27 males with the fragile site at Xq28. J Ment Defic Res (1983) 0.88
Neurobiology of Down's syndrome. Prog Neurobiol (1983) 0.87
Testicular biopsy in the study of male infertility. Arch Pathol (1973) 0.82
Abnormal neuronal differentiation (functional maturation) in mental retardation. Birth Defects Orig Artic Ser (1975) 0.81
Short stature, psychomotor retardation, and unusual facial appearance in two brothers. Am J Med Genet (1980) 0.81
Testicular changes in association with malformation of the central nervous system and mental retardation. Acta Pathol Microbiol Scand A (1971) 0.79
A method for the quantitative estimate of Leydig cells in the human testis. Proc Staff Meet Mayo Clin (1948) 0.79
Experience with prenatal fragile X detection. Am J Med Genet (1984) 0.79
Postnatal development of synaptic contact zones in the visual cortex of rabbits. Brain Res (1978) 0.79
Spermiogenesis in elderly men. Fertil Steril (1954) 0.78
The testes in the mentally handicapped. J Ment Defic Res (1973) 0.78
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A (1986) 10.13
Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol (1987) 7.05
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem (1986) 6.91
Abnormal fibrils from scrapie-infected brain. Acta Neuropathol (1981) 5.35
Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc Natl Acad Sci U S A (1987) 3.97
Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol (1985) 3.83
Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. Am J Med Genet (1999) 3.82
The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience (2000) 3.40
Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res (1989) 3.10
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition. Acta Neuropathol (1984) 2.97
Foetal thymic transplant in a case of Digeorge's syndrome. Lancet (1968) 2.85
Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet (1991) 2.70
Alzheimer paired helical filaments: immunochemical identification of polypeptides. Acta Neuropathol (1984) 2.70
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging (1997) 2.68
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Arch Neurol (2000) 2.66
What is too much variation? The null hypothesis in small-area analysis. Health Serv Res (1990) 2.63
Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA (1993) 2.59
Alzheimer neurofibrillary tangles: monoclonal antibodies to inherent antigen(s). Acta Neuropathol (1984) 2.58
Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet (1993) 2.57
Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. Ann Neurol (1979) 2.50
Evidence of founder chromosomes in fragile X syndrome. Nat Genet (1992) 2.38
Infection-specific particle from the unconventional slow virus diseases. Science (1984) 2.34
A complex mutable polymorphism located within the fragile X gene. Nat Genet (1993) 2.33
Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques. Acta Neuropathol (1983) 2.23
Evidence that Alzheimer neurofibrillary tangles originate from neurotubules. Lancet (1979) 2.22
Scrapie-associated fibrils in Creutzfeldt-Jakob disease. Nature (1984) 2.11
Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology (1992) 2.00
Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease. Ann Neurol (1999) 1.96
Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J Virol (1986) 1.95
Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus. J Clin Microbiol (1983) 1.91
Defective brain microtubule assembly in Alzheimer's disease. Lancet (1986) 1.89
Remyelination in multiple sclerosis. Ann Neurol (1979) 1.89
MRI of entorhinal cortex in mild Alzheimer's disease. Lancet (1999) 1.86
Ultrastructure of paired helical filaments of Alzheimer's neurofibrillary tangle. J Neuropathol Exp Neurol (1984) 1.86
The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol (1986) 1.77
Biochemical differences among scrapie-associated fibrils support the biological diversity of scrapie agents. J Gen Virol (1985) 1.75
Alzheimer's disease in Down's syndrome: clinicopathologic studies. Neurology (1985) 1.75
Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils. Acta Neuropathol (1992) 1.71
Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1. Hum Mol Genet (1997) 1.70
Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol (1997) 1.67
Detection of scrapie-associated fibril (SAF) proteins using anti-SAF antibody in non-purified tissue preparations. J Gen Virol (1986) 1.67
Fragile X gene instability: anchoring AGGs and linked microsatellites. Am J Hum Genet (1995) 1.61
Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalon. Acta Neuropathol (1984) 1.60
Inheritance of mitral valve prolapse: effect of age and sex on gene expression. Ann Intern Med (1982) 1.58
Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction. J Exp Med (1975) 1.57
Fragile X and autism: a multicenter survey. Am J Med Genet (1986) 1.56
Evidence for induction of localized amyloid deposits and neuritic plaques by an infectious agent. Ann Neurol (1981) 1.56
Detection of full fragile X mutation. Lancet (1992) 1.55
Familial transmission of the FMR1 CGG repeat. Am J Hum Genet (1996) 1.53
Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments. Brain Res (1988) 1.51
Congenital webs, cysts, laryngoceles and other anomalies of the larynx. Ann Otol Rhinol Laryngol (1967) 1.51
An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination. J Neuropathol Exp Neurol (1989) 1.51
Substructures of paired helical filaments from Alzheimer's disease neurofibrillary tangles. Acta Neuropathol (1985) 1.48
Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome. Am J Hum Genet (1993) 1.47
The FRAXE Syndrome: is it time for routine screening? Am J Hum Genet (1996) 1.46
Postnatal confirmation of prenatally diagnosed trisomy 16 mosaicism in two phenotypically abnormal liveborns. Prenat Diagn (1994) 1.46
The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet (1991) 1.46
FRAXAC1 and DXS548 polymorphisms in the Chinese population. Am J Med Genet (1999) 1.41
Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc Natl Acad Sci U S A (1989) 1.40
Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol (1995) 1.40
Alzheimer disease (AD): aspirin prophylaxis and therapy. Alzheimer Dis Assoc Disord (1992) 1.39
Alzheimer neurofibrillary tangles: antiserum and immunohistological staining. Ann Neurol (1979) 1.39
Agenesis of the corpus callosum and limbic malformation in Apert's syndrome. Arch Neurol (1989) 1.38
Alzheimer paired helical filaments: cross-reacting polypeptide/s normally present in brain. Acta Neuropathol (1985) 1.36
Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles. Acta Neuropathol (1987) 1.35
Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils. J Virol (1987) 1.35
Substructures of neurofilaments. Acta Neuropathol (1984) 1.34
Fmr1 knockout mouse has a distinctive strain-specific learning impairment. Neuroscience (2000) 1.32
Referral keeping in homeless women. J Community Health (1991) 1.32
The complex of microglial cells and amyloid star in three-dimensional reconstruction. Acta Neuropathol (1990) 1.31
Prevalence of intestinal parasite infections among individuals with mental retardation in New York State. Ment Retard (1995) 1.30
Guidelines for the diagnosis of fragile X syndrome. National Fragile X Foundation. J Med Genet (1993) 1.30
Neurofibrillary pathology--correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol Aging (1997) 1.30
The fine structure of chronically active multiple sclerosis plaques. Neurology (1978) 1.30
Alzheimer paired helical filaments: identification of polypeptides with monoclonal antibodies. Acta Neuropathol (1985) 1.27
Basal ganglia calcification (BGC) in Down's syndrome (DS)--another manifestation of premature aging. Ann N Y Acad Sci (1982) 1.26
Frequency of agenesis of the corpus callosum in the developmentally disabled population as determined by computerized tomography. Pediatr Neurosci (1986) 1.26
Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton. J Biol Chem (1998) 1.24
Mosaicism in fragile X affected males. Am J Med Genet (1994) 1.23
Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis. Arch Neurol (1979) 1.22
Chemical relationship of the paired helical filaments of Alzheimer's dementia to normal human neurofilaments and neurotubules. Brain Res (1978) 1.21
Normal adaptive function with learning disability in duplication 8p including band p22. Am J Med Genet (1998) 1.21
Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. Am J Hum Genet (1999) 1.21
Aluminum-induced neurofibrillary changes in axons and dendrites. Acta Neuropathol (1984) 1.18
Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. Biochem Biophys Res Commun (1992) 1.18
About the presence of paired helical filaments in dystrophic neurites participating in the plaque formation. Acta Neuropathol (1989) 1.18
Studies on demyelination by activated lymphocytes in the rabbit eye. II. Antibody-dependent cell-mediated demyelination. J Immunol (1977) 1.18
Ultrastructural observations on the transvascular route of protein removal in vasogenic brain edema. Acta Neuropathol (1985) 1.17
Peripheral nerve ischemia: Part 2. Accumulation of organelles. Ann Neurol (1978) 1.17
Chronic relapsing EAE. Time course of neurological symptoms and pathology. Acta Neuropathol (1978) 1.17